590 filings
Page 9 of 30
4
z4w 5zfb2oodjitg2
17 Dec 20
9 METERS BIOPHARMA / Mark A Sirgo ownership change
4:17pm
4
9d72hsa7
17 Dec 20
9 METERS BIOPHARMA / Edward J Sitar ownership change
4:17pm
SC 13D/A
f7xeuv3f7s44g7as49c
16 Dec 20
9 METERS BIOPHARMA / OrbiMed Israel BioFund GP Limited Partnership ownership change
5:13pm
8-K
3g9g 3v0b4
15 Dec 20
9 Meters Biopharma, Inc. Announces Proposed Public Offering of Common Stock
4:25pm
424B5
7896e1 cd
11 Dec 20
Prospectus supplement for primary offering
5:27pm
424B5
m6avtdz0maithc 09r
10 Dec 20
Prospectus supplement for primary offering
4:09pm
SC 13G/A
ekq5ih1nx7 6dms1fq
10 Dec 20
9 METERS BIOPHARMA / Capital Point ownership change
10:58am
8-K
n5s swj3c
9 Dec 20
Other Events
7:34am
8-K
h55dec
7 Dec 20
Other Events
7:40am
8-K
kun1 zv4xu7e
7 Dec 20
9 Meters Biopharma, Inc. Announces Positive Topline Data for NM-002, a Proprietary Long-Acting GLP-1, in Phase 1b/2a Trial for Short Bowel Syndrome
7:37am
4
6zb6g3x
1 Dec 20
9 METERS BIOPHARMA / John Temperato ownership change
4:10pm
8-K
qot5za3irx 786ylkg2i
27 Nov 20
Departure of Directors or Certain Officers
4:07pm
8-K
33alvlwjmpxvyulzgs8m
16 Nov 20
9 Meters Biopharma Announces Positive Preclinical Data for NM-102, a Gut Microbiome Modulator in an Immune Checkpoint Inhibitor Failure Model
7:51am
8-K
1ezicwxbzc62j6da3 29
9 Nov 20
9 Meters Biopharma, Inc. Provides Business Update and Announces Third Quarter 2020 Results
8:04am
4
19s7vaa
3 Nov 20
Change in insider ownership
4:14pm
4
dzf0mid1c2xn
3 Nov 20
9 METERS BIOPHARMA / Nissim Darvish ownership change
4:14pm
4
cl3trt3
3 Nov 20
9 METERS BIOPHARMA / Mark A Sirgo ownership change
4:14pm
4
gj02vfbjoi7vt4wpge4
3 Nov 20
9 METERS BIOPHARMA / John Temperato ownership change
4:13pm
8-K
bzdxmgpf0pl8iiq5rlz
2 Nov 20
9 Meters Biopharma, Inc. to participate in the following November
8:09am